1. Home
  2. ZONE vs SCYX Comparison

ZONE vs SCYX Comparison

Compare ZONE & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZONE
  • SCYX
  • Stock Information
  • Founded
  • ZONE 2022
  • SCYX 1999
  • Country
  • ZONE United States
  • SCYX United States
  • Employees
  • ZONE N/A
  • SCYX N/A
  • Industry
  • ZONE
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZONE
  • SCYX Health Care
  • Exchange
  • ZONE NYSE
  • SCYX Nasdaq
  • Market Cap
  • ZONE 19.3M
  • SCYX 28.5M
  • IPO Year
  • ZONE 2024
  • SCYX 2014
  • Fundamental
  • Price
  • ZONE $2.47
  • SCYX $0.71
  • Analyst Decision
  • ZONE
  • SCYX
  • Analyst Count
  • ZONE 0
  • SCYX 0
  • Target Price
  • ZONE N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • ZONE 96.1K
  • SCYX 115.9K
  • Earning Date
  • ZONE 05-14-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • ZONE N/A
  • SCYX N/A
  • EPS Growth
  • ZONE N/A
  • SCYX N/A
  • EPS
  • ZONE N/A
  • SCYX N/A
  • Revenue
  • ZONE $1,887,046.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • ZONE N/A
  • SCYX $463.61
  • Revenue Next Year
  • ZONE N/A
  • SCYX $310.80
  • P/E Ratio
  • ZONE N/A
  • SCYX N/A
  • Revenue Growth
  • ZONE 38.12
  • SCYX N/A
  • 52 Week Low
  • ZONE $0.81
  • SCYX $0.66
  • 52 Week High
  • ZONE $5.54
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • ZONE N/A
  • SCYX 39.58
  • Support Level
  • ZONE N/A
  • SCYX $0.70
  • Resistance Level
  • ZONE N/A
  • SCYX $0.75
  • Average True Range (ATR)
  • ZONE 0.00
  • SCYX 0.05
  • MACD
  • ZONE 0.00
  • SCYX 0.00
  • Stochastic Oscillator
  • ZONE 0.00
  • SCYX 28.80

About ZONE CLEANCORE SOLUTIONS INC

CleanCore Solutions Inc engages in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. The firm has a patented nanobubble technology using aqueous ozone that is effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: